---
title: "Seres Therapeutics (MCRB) Receives a Buy from H.C. Wainwright"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294983770.md"
description: "H.C. Wainwright analyst Matthew Keller reiterated a Buy rating on Seres Therapeutics (MCRB) with a $12 price target. This contrasts with the broader analyst consensus, which holds a Moderate Buy rating and an average price target of $17.00 for the healthcare stock."
datetime: "2026-08-05T14:36:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294983770.md)
  - [en](https://longbridge.com/en/news/294983770.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294983770.md)
generator: "portal-rs"
---

# Seres Therapeutics (MCRB) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Matthew Keller reiterated a Buy rating on Seres Therapeutics today and set a price target of $12.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Keller is an analyst with an average return of -25.9% and a 15.94% success rate. Keller covers the Healthcare sector, focusing on stocks such as Galectin Therapeutics, Seres Therapeutics, and 60 Degrees Pharmaceuticals, Inc..

Currently, the analyst consensus on Seres Therapeutics is a Moderate Buy with an average price target of $17.00.

### Related Stocks

- [MCRB.US](https://longbridge.com/en/quote/MCRB.US.md)
- [GALT.US](https://longbridge.com/en/quote/GALT.US.md)
- [SXTP.US](https://longbridge.com/en/quote/SXTP.US.md)
- [SXTPW.US](https://longbridge.com/en/quote/SXTPW.US.md)

## Related News & Research

- [Seres Therapeutics to present at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297640933.md)
- [Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Above 50 Day Moving Average   - Should You Sell?](https://longbridge.com/en/news/297874851.md)
- [AcuCort notifies availability of August 2026 newsletter press release](https://longbridge.com/en/news/297505730.md)
- [Morgan Stanley Remains a Buy on Rockwell Automation (ROK)](https://longbridge.com/en/news/297785354.md)
- [Morgan Stanley Sticks to Its Buy Rating for Trane Technologies (TT)](https://longbridge.com/en/news/297784931.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**